Monday, February 2, 2015

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.

Neither nonsteroidal anti-inflammatory drugs, proton pump inhibitors, low-dose aspirin nor statins were found to decrease the risk of high grade dysplasia or esophageal cancer in patients with Barrett Esophagus.  (BMJ Open. 2015 Jan 29;5(1):e006640.)
Read More